Disease-specific mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis
Younger age, higher on-therapy IGF-I and radiotherapy were associated with higher SMR for cardiovascular/cerebrovascular causes, highlighting the importance of achieving IGF-I normalization.
Authors
- Greisa Vila (ORCID: https://orcid.org/0000-0003-1918-1959)
- Martin Carlsson (ORCID: https://orcid.org/0000-0003-3106-0754)
- Lissette Cespedes
- Camilo Jiménez (ORCID: https://orcid.org/0000-0002-5292-3355)
- Nicholas A. Tritos (ORCID: https://orcid.org/0000-0001-8867-607X)
- Karen Klahr Miller (ORCID: https://orcid.org/0000-0001-9438-2449)
- Michael P. Wajnrajch (ORCID: https://orcid.org/0000-0002-8211-9237)
- Beverly M. K. Biller (ORCID: https://orcid.org/0000-0003-4359-4622)
- Daria La Torre
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- Pfizer (United States) (US)
- Massachusetts General Hospital (US)
- Pfizer (Italy) (IT)
- New York University (US)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Endocrine Connections
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1530/ec-25-0247
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00